Valchlor: Clinical Trials

4 trials of Valchlor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown, 1 withdrawn. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Unknown 1, Withdrawn 1

Follow Valchlor: new trials by email Literature Review of Valchlor trials Research Report on Valchlor

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Hypericin, Mechlorethamine Topical Gel - Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Phase 2CompletedSoligenix102023-12-052025-08-20
Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides
Mechlorethamine Hydrochloride Gel, Total Skin Electron Beam Radiation Therapy - Mycosis Fungoides
Phase 2WithdrawnSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2018-08-012025-04-29
Valchlor in the Treatment of Lichen Planopilaris
Mechlorethamine 0.016% Top Gel - Lichen Planopilaris
Phase 2CompletedMayo Clinic122018-04-012021-01-28
Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides
Total skin electron beam therapy (TSEBT), mechlorethamine gel 0.016% - Mycosis Fungoides, Cutaneous T-cell Lymphoma
Phase 2UnknownThomas Jefferson University682016-09-012016-08-30

Conditions studied

Mycosis Fungoides (3)  ·  Lichen Planus (1)  ·  Lymphoma, T-Cell, Cutaneous (1)

Sponsors

Mayo Clinic (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  Soligenix (1)  ·  Thomas Jefferson University (1)

Countries

United States (3)

Top investigators

Jason Sluzevich, MD (1)  ·  Joya Sahu, MD (1)

Results publications

PMID 41920467